Drug Profile
Streptococcal A vaccine intranasal - Active Biotech/ID Biomedical
Latest Information Update: 12 Jun 2003
Price :
$50
*
At a glance
- Originator Active Biotech; ID Biomedical Corporation
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Streptococcal infections
Most Recent Events
- 12 Jun 2003 Discontinued - Preclinical for Streptococcal infections in Canada (Intranasal)
- 12 Jun 2003 Discontinued - Preclinical for Streptococcal infections in Sweden (Intranasal)
- 05 Jun 2001 Intellivax has been acquired by ID Biomedical Corporation